Treatment of influenza virus infection
AssigneesThe Administrators of the Tulane, Educational Fund and Autoimmune Technologies, LLC
InventorsRobert F. Garry, Russell B. Wilson
Life of this patent
Estimating the term…
Abstract
The present invention provides methods for the treatment of an ongoing influenza infection by administering a polypeptide to a subject suffering from an influenza infection. The polypeptide consists of SEQ ID NO: 4. The present invention also provides a method of interfering with fusion of an influenza virus envelope with a host cell membrane by contacting the host cell with a polypeptide consisting of SEQ ID NO: 4.
Claims3
A method of interfering with fusion of an influenza virus envelope with a host cell membrane comprising:
- contacting an influenza virus with a polypeptide consisting of SEQ ID NO:
- 4.
A method for treating an ongoing influenza virus infection by inhibiting fusion of the virus with a host cell membrane, the method comprising:
- administering to a subject suffering from an influenza infection a polypeptide consisting of SEQ ID NO:
- 4.
A method for treating an ongoing influenza virus infection by inhibiting fusion of the virus with a host cell membrane, the method comprising:
- administering to a subject suffering from an influenza infection a polypeptide consisting of SEQ ID NO:
- 4;
- wherein the administering step comprises intranasally administering the polypeptide.
Dependencies are inferred from the claim text.